Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 602-607, March 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudman, D.
Right arrow Articles by Shah, V. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudman, D.
Right arrow Articles by Shah, V. R.

Isolation of Novel Glycoprotein HNC1ß from the Urine of a Patient with Acute Monocytic Leukemia1

Daniel Rudman2, Rajender K. Chawla, Daniel W. Nixon, John H. Roler and Vinod R. Shah

Department of Medicine, Emory University School of Medicine, and Clinical Research Facility, Emory University Hospital, Atlanta, Georgia 30322

Patient H. N. with acute monocytic leukemia excreted 150 to 300 mg of urinary protein per day; gel filtration showed 70% to be in the M. W. range of 20,000 to 40,000. By repeated gel filtration, and cation- and anion-exchange chromatography, the major urinary protein, labeled HNC1ß, was isolated in a yield of 10 to 30 mg/liter of urine. HNC1ß did not react with antisera to any of the recognized normal plasma proteins or to previously isolated cancer-related urinary proteins. HNC1ß contains 40% carbohydrate and 60% protein; molecular weight is 33,000. Amino acid compositions of HNC1ß and EDC1, a glycoprotein previously isolated from the urine of a patient with acute myelocytic leukemia, are closely similar, while the carbohydrate compositions differ widely.

An antiserum to HNC1ß was raised in the rabbit and a radioimmunoassay capable of detecting 10 ng of the glycoprotein was developed. Normal and cancer plasma contained similar amounts of an unidentified factor, about 150,000 in molecular weight, which reacts in the radioimmunoassay. Urine from normal individuals and 9 nonneoplastic diseases contained <0.1 mg of HNC1ß per g of creatinine. Urine from patients with 11 types of disseminated cancer (ovary, breast, lung, colon, squamous head and neck, melanoma, acute and chronic leukemias of myelocytic, monocytic and lymphocytic varieties) contained 1.7 to 27 mg of HNC1ß per g of creatinine.

1 Supported by USPHS Grants CA12646, RR00039, and CA20997.

2 To whom requests for reprints should be addressed.

Received 8/12/77. Accepted 11/23/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.